Skip to main content

ZAGOTENEMAB

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number2019133-28-7
Known Aliases (7)
Common Name
IMMUNOGLOBULIN G4, ANTI-(TAU PROTEIN) (HUMAN MONOCLONAL LY3303560 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3303560 LIGHT CHAIN, DIMER IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MICROTUBULE-ASSOCIATED PROTEIN TAU (NEUROFIBRILLARY TANGLE PROTEIN, PHF-TAU)) HUMANIZED MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-442) (HUMANIZED VH (HOMO SAPIENS IGHV5-51*01 (85%) (IGHD)-IGHJ4*01 (87%)) (8.8.9) (1-116) -HOMO SAPIENS IGHG4*01 (HINGE(S10>P(224)), CH2(F4>A(230),L5>A(231)), CH3(K107>DEL(443))) (117-442)) (130-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-20*01 (79%) IGKJ4*01)(11.3.9) (1'-112') -HOMO SAPIENS IGKC*01 (113'-219')), DIMER (222-222'':225-225'')-BISDISULFIDE LY-3303560 LY3303560 zagotenemab [INN] ZAGOTENEMAB [USAN] Zagotenemab [WHO-DD]
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) AY6V5E2GNX ZAGOTENEMAB CAS: 2019133-28-7
INN: 11050
USAN: FG-107
SMS_ID: 300000010808
FDA UNII: AY6V5E2GNX
NCI_THESAURUS: C171842
Record Info
IDWPmLJvgvdrywYrYcmTjdFW
CreatedApril 10, 2026, 9:43 p.m.
ModifiedApril 10, 2026, 11:04 p.m.
Data SourceFDA Substance Registry (openFDA)